U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3021130211Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?RecruitingNo Results AvailableAcute Coronary SyndomeOther: Blood Test|Other: EndoPAT - endothelial assessmenthttps://ClinicalTrials.gov/show/NCT02169596
3021230212Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult SubjectsCompletedNo Results AvailableInfections, Respiratory TractDrug: GSK1325756 Solution|Drug: GSK1325756 Solution Matching Placebo|Drug: GSK1325756 Tablet|Drug: GSK1325756 Tablet Matching Placebohttps://ClinicalTrials.gov/show/NCT02169583
3021330213Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary TuberculosisNot yet recruitingNo Results AvailableType 2 Diabetes Mellitus|Pulmonary TuberculosisDietary Supplement: Vitamin D|Dietary Supplement: Calcium|Dietary Supplement: Placebo Vit D|Dietary Supplement: Placebo Calciumhttps://ClinicalTrials.gov/show/NCT02169570
3021430214Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal StudyRecruitingNo Results AvailableHuman African Trypanosomiasis (HAT)Drug: Fexinidazolehttps://ClinicalTrials.gov/show/NCT02169557
3021530215Post-marketing Study Assessing the Long-Term Safety of AbataceptActive, not recruitingNo Results AvailableRheumatoid ArthritisDrug: Abatacepthttps://ClinicalTrials.gov/show/NCT02169544
3021630216Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes MellitusRecruitingNo Results AvailableType 2 Diabetes Mellitus|HyperglycemiaDrug: ex vivo Activated Immune Cellshttps://ClinicalTrials.gov/show/NCT02169531
3021730217Paraoxonase and HDL Qualities in Glycaemia and InflammationRecruitingNo Results AvailableDiabetes.|Bariatric Surgery.https://ClinicalTrials.gov/show/NCT02169518
3021830218Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)RecruitingNo Results AvailableLymphomaDrug: Brentuximab Vedotinhttps://ClinicalTrials.gov/show/NCT02169505
3021930219Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic StrokeRecruitingNo Results AvailableStrokehttps://ClinicalTrials.gov/show/NCT02169492
3022030220Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/CarbidopaCompletedHas ResultsParkinson's Disease (PD)Drug: BIA 9-1067|Drug: Placebo|Drug: Sinemet® 100/25https://ClinicalTrials.gov/show/NCT02169479
3022130221Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/BenserazideCompletedNo Results AvailableParkinson's Disease (PD)Drug: BIA 9-1067 25 mg dose|Drug: BIA 9-1067 50 mg dose|Drug: BIA 9-1067 100 mg dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02169466
3022230222Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/CarbidopaCompletedHas ResultsParkinson's Disease (PD)Drug: BIA 9-1067|Drug: Placebo|Drug: Sinemet® CR 100/25https://ClinicalTrials.gov/show/NCT02169453
3022330223Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of WarfarinCompletedNo Results AvailableParkinson's Disease (PD)Drug: 25 mg BIA 9-1067|Drug: 25 mg warfarinhttps://ClinicalTrials.gov/show/NCT02169440
3022430224An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and MetabolitesCompletedHas ResultsParkinson's Disease (PD)Drug: OPChttps://ClinicalTrials.gov/show/NCT02169427
3022530225Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa PharmacokineticsCompletedNo Results AvailableParkinson's Disease (PD)Drug: BIA 9 1067 5 mg dose|Drug: BIA 9 1067 15 mg dose|Drug: BIA 9 1067 50 mg dose|Drug: levodopa/carbidopa 100/25|Drug: Placebo|Drug: levodopa/benserazide 100/25 mghttps://ClinicalTrials.gov/show/NCT02169414
3022630226A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic PainRecruitingNo Results AvailableChronic PainDevice: Implantation with the commercially available Axium Neurostimulatorhttps://ClinicalTrials.gov/show/NCT02169401
3022730227Intestinal Microflora in Colorectal Cancer (CRC) After ChemotherapyRecruitingNo Results AvailableGastrointestinal Neoplasms|Colorectal Cancer|Effects of Chemotherapy|Tumor Immunity|MalnutritionDrug: Probiotic|Drug: placebo(for probiotic)https://ClinicalTrials.gov/show/NCT02169388
3022830228Sensorimotor Based Brain Computer InterfaceTerminatedNo Results AvailableHealthy VolunteersOther: Brain computer Interface Mu (SMR) rhythmhttps://ClinicalTrials.gov/show/NCT02169375
3022930229Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal InjuriesRecruitingNo Results AvailableAcute Deep Partial Thickness Thermal BurnsDevice: Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™)https://ClinicalTrials.gov/show/NCT02169362
3023030230Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung CancerRecruitingNo Results AvailableStage IIIb and IV Non Small Cell Lung CancerOther: laboratory biomarker analysis|Other: Next Generation Sequencing|Genetic: DNA Analysishttps://ClinicalTrials.gov/show/NCT02169349
3023130231Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following BunionectomyCompletedNo Results AvailablePain, Post-operativeDrug: Intranasal Dexmedetomidine|Other: Intranasal Placebohttps://ClinicalTrials.gov/show/NCT02169336
3023230232Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic AsthmaticsRecruitingNo Results AvailableAsthmaOther: Step-downhttps://ClinicalTrials.gov/show/NCT02169323
3023330233Neural Basis of Decision-Making Deficits in Traumatic Brain InjuryRecruitingNo Results AvailableTraumatic Brain Injuryhttps://ClinicalTrials.gov/show/NCT02169310
3023430234Sub-Paraspinal Block in Nuss Patients. A Pilot ProjectCompletedNo Results AvailablePectus Excavatum|Pain, PostoperativeProcedure: Ultrasound-guided Sub-Paraspinal Block|Procedure: PCA onlyhttps://ClinicalTrials.gov/show/NCT02169297
3023530235Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing SurgeryRecruitingNo Results AvailableRecurrent Bladder Carcinoma|Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder CancerDrug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Other: Placebo|Procedure: Therapeutic Conventional Surgeryhttps://ClinicalTrials.gov/show/NCT02169284
3023630236Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung NodulesRecruitingNo Results AvailableSolitary Pulmonary Nodule|Tobacco Use DisorderDrug: Aspirin|Other: Laboratory Biomarker Analysis|Other: Placebohttps://ClinicalTrials.gov/show/NCT02169271
3023730237Routine Coronary Catheterization in Low Extremity Artery Disease Undergoing Percutaneous Transluminal AngioplastyRecruitingNo Results AvailablePeripheral Artery Disease|Coronary Artery DiseaseProcedure: Systemic Strategyhttps://ClinicalTrials.gov/show/NCT02169258
3023830238Effects of Protein and Fiber at Breakfast on Appetite, Blood Sugar, and CholesterolActive, not recruitingNo Results AvailableBrain Activity|Appetite|Ingestive Behavior|Glucose Control|CholesterolOther: Dietary control of protein and fiber intake at breakfasthttps://ClinicalTrials.gov/show/NCT02169245
3023930239Videolaryngoscope Versus Fiberoptic Bronchoscope for the Awake IntubationRecruitingNo Results AvailableNeed of Awake Intubation for Difficult AirwaysDevice: Videolaryngoscope|Device: Fiberoptichttps://ClinicalTrials.gov/show/NCT02169232
3024030240Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated VasculitisRecruitingNo Results AvailableGranulomatosis With Polyangiitis|Microscopic PolyangiitisDrug: Glucocorticoids|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT02169219

* Görseller ve İçerik tekif hakkına sahip olabilir